G1 CYTOSTATIC AGENTS ENHANCING ANTIVIRAL ACTIVITY OF VIRAL-ENVELOPE TARGETING DRUGS AND ANTIBODIES

摘要

The present invention relates to a combination therapy comprising viral-envelope targeting drugs and/or antibodies in combination with Gl cytostatic agents having the functional activity of reducing transcription of CCR5 thereby causing a reduced number of surface receptors for binding of HIV gpl20.